During the past decade, Complejo Asistencial de Avila conducted 6 clinical trials. In the 10-year time frame, 6 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 5 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Complejo Asistencial de Avila" #1 sponsor was "PETHEMA Foundation" with 2 trials, followed by "Abbott Nutrition" with 1 trials sponsored, "Fresenius Medical Care Deutschland GmbH" with 1 trials sponsored, "Fundacion SEIMC-GESIDA" with 1 trials sponsored and "Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau" with 1 trials sponsored. Other sponsors include -4 different institutions and companies that sponsored additional 6 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Complejo Asistencial de Avila" #1 collaborator was "Adknoma Health Research" with 1 trials as a collaborator, "Dynamic Science S.L." with 1 trials as a collaborator, "GlaxoSmithKline" with 1 trials as a collaborator, "Janssen, LP" with 1 trials as a collaborator and "Millennium Pharmaceuticals, Inc." with 1 trials as a collaborator. Other collaborators include -5 different institutions and companies that were collaborators in the rest 5 trials.

According to Clinical.Site data, the most researched conditions in "Complejo Asistencial de Avila" are "Breast Cancer" (1 trials), "Breast Cancer Metastatic" (1 trials), "Chronic Renal Failure" (1 trials), "Covid19" (1 trials) and "Leukemia, Myeloid, Acute" (1 trials). Many other conditions were trialed in "Complejo Asistencial de Avila" in a lesser frequency.

Most popular intervention types in "Complejo Asistencial de Avila" are "Drug" (3 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "Aromatase Inhibitors" (1 trials), "Azacitidine" (1 trials), "Bortezomib" (1 trials), "Daratumumab" (1 trials) and "Niraparib 100 MG" (1 trials). Other intervention names were less common.

The vast majority of trials in "Complejo Asistencial de Avila" are 6 trials for "All" genders and 1 trials for "Female" genders.

Currently, there are NaN active trials in "Complejo Asistencial de Avila". undefined are not yet recruiting, 2 are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 3 completed trials in Complejo Asistencial de Avila, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Complejo Asistencial de Avila, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 1 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".